Research identifies estrogen receptor beta as a potential brake on inflammatory breast cancer spread, opening doors to targeted therapies and improved outcomes for patients with this aggressive disease.

Researchers are exploring ultra-high dose methylcobalamin for ALS, offering potential new treatment options that may slow disease progression and bring hope to patients and families.

Ancient bacterial defenses against viruses inspire novel antiviral strategies, offering alternatives amid antibiotic resistance and promising safer, targeted treatments for human health and food safety.

Male factor infertility carries emotional and social impacts, highlighting the need to reduce stigma, support men’s mental health, and promote inclusive, couple-centered fertility care.

Study suggests women with Sjögren syndrome face higher breast cancer risk, underscoring the need for heightened screening awareness, personalized care, and informed patient–provider discussions.

Genomic testing enables personalized prostate cancer treatment, but disparities in access persist, highlighting the need for equitable policies ensuring all patients benefit from precision medicine advances.

Safely reducing broad-spectrum antibiotics in improving sepsis patients may curb resistance, lower side effects, and maintain recovery, prompting hospitals to rethink antibiotic de-escalation practices nationwide.

Breast cancer patients receiving neoadjuvant therapy show changing quality-of-life needs, emphasizing personalized emotional support to improve wellbeing, treatment adherence, and overall outcomes throughout care.

Treatment-resistant postpartum depression leaves some mothers without relief, highlighting urgent needs for identifying risk factors, personalized care, and better support to improve recovery for families.

Many commercially insured Americans live with chronic conditions, driving higher healthcare costs and underscoring the need for improved prevention, management strategies, and informed policy decisions.